CA1157774A - Methode pour diminuer la viscosite de la mucine - Google Patents

Methode pour diminuer la viscosite de la mucine

Info

Publication number
CA1157774A
CA1157774A CA000357356A CA357356A CA1157774A CA 1157774 A CA1157774 A CA 1157774A CA 000357356 A CA000357356 A CA 000357356A CA 357356 A CA357356 A CA 357356A CA 1157774 A CA1157774 A CA 1157774A
Authority
CA
Canada
Prior art keywords
viscosity
sputum
pharmaceutical composition
composition according
mucin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000357356A
Other languages
English (en)
Inventor
Anthony Cerami
Nina F. Tavachnik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Priority to CA000357356A priority Critical patent/CA1157774A/fr
Application granted granted Critical
Publication of CA1157774A publication Critical patent/CA1157774A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000357356A 1980-07-30 1980-07-30 Methode pour diminuer la viscosite de la mucine Expired CA1157774A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000357356A CA1157774A (fr) 1980-07-30 1980-07-30 Methode pour diminuer la viscosite de la mucine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000357356A CA1157774A (fr) 1980-07-30 1980-07-30 Methode pour diminuer la viscosite de la mucine

Publications (1)

Publication Number Publication Date
CA1157774A true CA1157774A (fr) 1983-11-29

Family

ID=4117544

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000357356A Expired CA1157774A (fr) 1980-07-30 1980-07-30 Methode pour diminuer la viscosite de la mucine

Country Status (1)

Country Link
CA (1) CA1157774A (fr)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218096A (en) * 1985-06-14 1989-11-08 Oreal Hydroxy ether compounds
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
US5646189A (en) * 1993-10-15 1997-07-08 Thoene; Jess G. Prevention of HIV infection
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
WO1998052551A1 (fr) * 1997-05-22 1998-11-26 Kyowa Hakko Kogyo Co., Ltd. Composes bisaryle et remedes contre le cancer contenant ces composes
JP2005526129A (ja) * 2002-05-17 2005-09-02 デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗結核薬剤、組成物および方法
US8198303B2 (en) 2002-05-17 2012-06-12 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious diseases
JP2012524121A (ja) * 2009-04-20 2012-10-11 アボット・ラボラトリーズ 新規アミドおよびアミジン誘導体ならびにこれらの使用
WO2017207428A1 (fr) * 2016-05-29 2017-12-07 Beyond Cosmeceuticals Sa Utilisation de dérivés de thiophosphate comme agents de dépigmentation de la peau
EP3656381A1 (fr) * 2018-11-23 2020-05-27 I.E.R.F.C. European Institute for Cystic Fibrosis Research Analogues de cystéamine en tant qu'agents thérapeutiques pour le traitement de la mucoviscidose
CN111803477A (zh) * 2020-08-11 2020-10-23 上海交通大学 戒酒硫在制备抗头颈癌和抗纤维化药物中的用途

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218096A (en) * 1985-06-14 1989-11-08 Oreal Hydroxy ether compounds
GB2218096B (en) * 1985-06-14 1990-04-04 Oreal Hydroxy ether compounds
US5008406A (en) * 1985-06-14 1991-04-16 L'oreal Hemiacetal compounds and the applications thereof
US5164488A (en) * 1985-06-14 1992-11-17 L'oreal New hemiacetal compounds and the applications thereof
US5554655A (en) * 1991-09-30 1996-09-10 Jess G. Thoene Method of treating HIV infection
US5646189A (en) * 1993-10-15 1997-07-08 Thoene; Jess G. Prevention of HIV infection
US5725870A (en) * 1993-10-15 1998-03-10 Thoene; Jess G. Methods, composites and articles for contraception
US6608061B2 (en) 1997-05-22 2003-08-19 Kyoma Hakko Kogyo Co., Ltd. Bisaryl compound and medicament for cancer treatment comprising the same
WO1998052551A1 (fr) * 1997-05-22 1998-11-26 Kyowa Hakko Kogyo Co., Ltd. Composes bisaryle et remedes contre le cancer contenant ces composes
JP2005526129A (ja) * 2002-05-17 2005-09-02 デパートメント オブ ヘルス アンド ヒューマン サービシーズ 抗結核薬剤、組成物および方法
US8198303B2 (en) 2002-05-17 2012-06-12 Sequella, Inc. Methods of use and compositions for the diagnosis and treatment of infectious diseases
US8268894B2 (en) 2002-05-17 2012-09-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for the treatment of infectious diseases
JP2012524121A (ja) * 2009-04-20 2012-10-11 アボット・ラボラトリーズ 新規アミドおよびアミジン誘導体ならびにこれらの使用
WO2017207428A1 (fr) * 2016-05-29 2017-12-07 Beyond Cosmeceuticals Sa Utilisation de dérivés de thiophosphate comme agents de dépigmentation de la peau
US11096881B2 (en) 2016-05-29 2021-08-24 Scientis, SA Use of thiophosphate derivatives as skin depigmenting agents
EP3656381A1 (fr) * 2018-11-23 2020-05-27 I.E.R.F.C. European Institute for Cystic Fibrosis Research Analogues de cystéamine en tant qu'agents thérapeutiques pour le traitement de la mucoviscidose
CN111803477A (zh) * 2020-08-11 2020-10-23 上海交通大学 戒酒硫在制备抗头颈癌和抗纤维化药物中的用途

Similar Documents

Publication Publication Date Title
US4424216A (en) Method for the reduction of mucin viscosity
CA1157774A (fr) Methode pour diminuer la viscosite de la mucine
PL204623B1 (pl) Oligosacharydy, sposób ich wytwarzania, kompozycje farmaceutyczne zawierające je oraz ich zastosowanie
US5290815A (en) Treatment of inflammation and allergy
PETERS Significance of biochemical lesions in the pyruvate oxidase system
NO305992B1 (no) Halvsyntetiske glykosaminglykosaner med heparin- eller heparanstruktur og fremgangsmåte til fremstilling derav
US5663203A (en) Agents containing prostacyclin derivatives for topical application
CA1312090C (fr) Derive d'hydroxyalkylcysteine et expectorant contenant celui-ci
GR3019917T3 (en) Benzimidazole derivatives as antimicrobal agent against campylobacter pylon
US5631234A (en) Method for treating ischemia-reperfusion tissue injury
Flippin et al. Sulfapyridine and sulfathiazole therapy in pneumococcic pneumonia
JP3196106B2 (ja) ロイコトリエンａ４ヒドロラーゼ阻害剤
ES2258145T3 (es) Disacaridos hipersulfatados y procedimientos para la utilizacion de los mismos en el tratamiento de las inflamaciones.
CA2072106A1 (fr) Cephalosporines et methode de production
JP3769045B2 (ja) 抗炎症剤
JPS6029701B2 (ja) 新規なヒドロキサム酸化合物およびその製造方法ならびにそれを含有する医薬
US4874776A (en) Compound having mucus regulating and elastase-inhibitory activities, for the therapy of pulmonal emphysema and pulmonal fibrosis
EP0538476B1 (fr) Traitement preventif ou curatif pour l'ischemie, les troubles tissulaires induits par la reperfusion et l'arythmie, ainsi que les troubles pulmonaires provoques par un radical libre d'oxygene active
AU588960B2 (en) New nitrogen-arylmethoxy-thiophene derivatives and acid addition salts thereof, processes for their preparation and pharmaceutical preparations containing these compounds
Fox et al. Inhibitory effects of gold salts in adjuvant arthritis and on lysosomal enzyme activity [proceedings]
CA2387199A1 (fr) Remedes pour plaies chroniques
JPS58113172A (ja) チオアルカノイル−カルニチン誘導体、その製造法およびそれを有効成分とする医薬
JP3284206B2 (ja) アズロイルアミノ酸誘導体
US5614554A (en) Reverse transcriptase inhibitors and antiviral agents
WO1990003374A1 (fr) 1,4-dihydrothionapthoquinone et congeneres heterocycliques qui inhibent les enzymes lipoxygenase

Legal Events

Date Code Title Description
MKEX Expiry